Cart
sales@molnova.com
glycohyodeoxycholic acid
CAS No. 13042-33-6
glycohyodeoxycholic acid( —— )
Catalog No. M21219 CAS No. 13042-33-6
glycohyodeoxycholic acid is a major metabolite of the secondary bile acid hyodeoxycholic acid in humans.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 120 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Nameglycohyodeoxycholic acid
-
NoteResearch use only, not for human use.
-
Brief Descriptionglycohyodeoxycholic acid is a major metabolite of the secondary bile acid hyodeoxycholic acid in humans.
-
Descriptionglycohyodeoxycholic acid is a major metabolite of the secondary bile acid hyodeoxycholic acid in humans.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13042-33-6
-
Formula Weight449.6
-
Molecular FormulaC26H43NO5
-
Purity>98% (HPLC)
-
SolubilityDMSO:20mg/ml(44.48mM)
-
SMILESC[C@H](CCC(NCC(O)=O)=O)[C@@H](CC1)[C@@](C)(CC2)[C@@H]1[C@H](C1)[C@H]2[C@@](C)(CC[C@H](C2)O)[C@@H]2[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mcsherry C K Mosbach E H Cohen B I et al. Hyodeoxycholic acid: A new approach to gallstone prevention[J]. The American Journal of Surgery 1985 149(1):126-132.
molnova catalog
related products
-
Ruplizumab
Ruplizumab (BG 9588), a humanized monoclonal IgG1κ antibody targeting CD40L (TNF Receptor), holds promise for research in systemic lupus erythematosus disease .
-
Sirpiglenastat
Sirpiglenastat (DRP-104), a glutamine antagonist and prodrug of DON, exhibits antitumor activity by inhibiting glutamine metabolism and stimulating both the innate and adaptive immune systems.
-
Isolappaol A
Isolappaol A is a natural product for research related to life sciences.
